Pancreatic cancers change identity as they transform into aggressive types
In contrast to other commonly diagnosed cancers like colorectal and lung cancer, the 5-year survival…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
WCLC 2024: NeoCOAST-2 Data shows combination of durvalumab with novel agents increases pathological responses in resectable NSCLC
Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd…
WCLC 2024: Perioperative nivolumab may provide meaningful improvement in event-free survival compared to only neoadjuvant nivolumab plus chemotherapy for resectable NSCLC
New data from landmark analysis presented today report a decreased risk of disease recurrence or…
WCLC 2024: PanCan nodule management protocol more effective than LungRADSv1.1 method
New data presented today reveals that the PanCan nodule management protocol demonstrates superior performance in…
Dysfunctional white blood cells linked to heightened melanoma risk
About 8 to 10 million Americans over age 40 have an overabundance of cloned white…
Artificial intelligence platform demonstrates promising results in effectively treating a patient with a rare cancer
Rare diseases affect fewer than 1 in 2,000 people individually. However, with over 7,000 different…
Prostate cancer rates across Europe since 1980 “indicative of overdiagnosis” say experts
Rates of prostate cancer across Europe since 1980 are “indicative of overdiagnosis”, say researchers in…
Study advances in the selective elimination of cancer cells using molecular ‘cages’
Chemotherapy saves lives of cancer patients. However, these treatments are not without side effects and…
Researchers reveal key LAG3 mechanisms that could transform cancer immunotherapy
Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack…
Study solves testosterone’s paradoxical effects in prostate cancer
A treatment paradox has recently come to light in prostate cancer: Blocking testosterone production halts…